Herbas VPB

Print
EN | LT
LT - Anti-CTLA-4 antikūnai ir jų naudojimo būdai
EN - ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

Legal status

Patent lapsed (non-payment of fees)

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
European patent
(11) Number of the document 3303394
(13) Kind of document T
(96) European patent application number 16728509.7
Date of filing the European patent application 2016-05-27
(97) Date of publication of the European application 2018-04-11
(45) Date of publication and mention of the grant of the patent 2020-04-08
(46) Date of publication of the claims translation 2020-10-12
PCT application
(86) Number PCT/US2016/034508
Date 2016-05-27
PCT application publication
(87) Number WO 2016/196237
Date 2016-12-08
Priority applications
(30) Number Date Country code
201562168391 P 2015-05-29 US
201562182363 P 2015-06-19 US
201562190653 P 2015-07-09 US
201562257202 P 2015-11-18 US
201662280263 P 2016-01-19 US
201662292500 P 2016-02-08 US
201662294558 P 2016-02-12 US
201662323226 P 2016-04-15 US
Inventors
(72)
van DIJK, Marc, NL
MUNDT, Cornelia, Anne, DE
RITTER, Gerd, US
SCHAER, David, US
WOLCHOK, Jedd, David, US
MERGHOUB, Taha, US
SAVITSKY, David, Adam, US
FINDEIS, Mark, Arthur, US
WILSON, Nicholas, Stuart, US
Grantee
(73) Ludwig Institute for Cancer Research Ltd, Stadelhoferstrasse 22, 8001 Zürich, CH
Agenus Inc., 3 Forbes Road, Lexington, MA 02421, US
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Anti-CTLA-4 antikūnai ir jų naudojimo būdai
  ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2020-05-27
Last update date 2021-10-22